Tiziana Life Sciences Cash Flow Statement (2017-2025) | TLSA

Cash Flow Statement Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Operating Activities
Depreciation and Depletion (Quarter) -50.00
Non-cash Items (Quarter) 2.69M1.03M1.35M1.42M0.44M0.49M3.94M8.78M0.06M
Depreciation, Depletion & Amortization
Amortization (Quarter) 4.67M5.63M6.47M6.19M7.17M6.51M7.72M6.85M6.18M5.28M3.94M9.07M7.35M7.40M
Depreciation & Amortization (CF) (Quarter) -50.00
Change in Working Capital
Change in Accured Expenses (Quarter) 6.47M7.70M
Other Working Capital Changes (Quarter) 1.62M1.30M0.87M0.30M0.69M0.22M0.35M0.14M0.52M
Additional items
Exchange Rate Effect (Quarter) -26.00